Abstract

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease.
Carla Em Hollak ... Marieke Biegstraaten
Orphanet journal of rare diseases | VOL. 9
Carla Em Hollak, et. al.Carla Em Hollak ... Marieke Biegstraaten
14 Apr 2014
The cost-effectiveness of enzyme replacement therapy (ERT) for the infantile form of Pompe disease: comparing a high-income country's approach (England) to that of a middle-income one (Colombia)
Héctor E Castro- Jaramillo
Revista de Salud Pública | VOL. 14
Héctor E Castro- JaramilloHéctor E Castro- Jaramillo
01 Feb 2012
Cost-effectiveness of enzyme replacement therapy for Fabry disease
Carla Em Hollak ... Marcel Gw Dijkgraaf
Orphanet Journal of Rare Diseases | VOL. 8
Carla Em Hollak, et. al.Carla Em Hollak ... Marcel Gw Dijkgraaf
19 Feb 2013
Cost-effectiveness of Enzyme Replacement Therapy for Fabry Disease
Saskia Rombach ... Gabor Linthorst
Molecular Genetics and Metabolism | VOL. 105
Saskia Rombach, et. al.Saskia Rombach ... Gabor Linthorst
19 Jan 2012
View more papers

More From: Health Technology Assessment

Paper Title
Journal
Date
Author
Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT
-
Health Technology Assessment | VOL. 27
--
01 Dec 2023
Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: the PEACOCK study
Marcus Green ... Virginia Chiocchia
Health Technology Assessment | VOL. 27
Marcus Green, et. al.Marcus Green ... Virginia Chiocchia
01 Dec 2023
Project publication: Two-year follow-up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
Louise Linsell ... Stephen Robson
Health Technology Assessment | VOL. 27
Louise Linsell, et. al.Louise Linsell ... Stephen Robson
01 Dec 2023
Project publication: Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
Carolyn Gill ... Rachael Hunter
Health Technology Assessment | VOL. 27
Carolyn Gill, et. al.Carolyn Gill ... Rachael Hunter
01 Dec 2023
View more papers